GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Jan 2020 11:01 AM
RNS
Director/PDMR Shareholding
13 Jan 2020 10:34 AM
RNS
Director/PDMR Shareholding
08 Jan 2020 04:30 PM
RNS
GSK publishes provisional 2020 Dividend Dates
08 Jan 2020 03:11 PM
RNS
GSK publishes 2020 Dividend Dates
08 Jan 2020 02:37 PM
RNS
GSK Announces addition to Corporate Executive Team
02 Jan 2020 09:58 AM
RNS
Total Voting Rights
23 Dec 2019 07:01 AM
RNS
ViiV Healthcare receives complete response letter
18 Dec 2019 05:12 PM
RNS
Director/PDMR Shareholding
18 Dec 2019 04:55 PM
RNS
Director/PDMR Shareholding
17 Dec 2019 09:00 AM
RNS
Blocklisting Application
13 Dec 2019 04:48 PM
RNS
Director/PDMR Shareholding
11 Dec 2019 04:57 PM
RNS
Director/PDMR Shareholding
05 Dec 2019 12:00 PM
RNS
ViiV submits NDA to FDA for fostemsavir
04 Dec 2019 05:34 PM
RNS
Emma Walmsley - External Appointment
02 Dec 2019 05:52 PM
RNS
Director/PDMR Shareholding
02 Dec 2019 04:54 PM
RNS
Total Voting Rights
26 Nov 2019 03:00 PM
RNS
Block listing Interim Review
12 Nov 2019 03:51 PM
RNS
Director/PDMR Shareholding
08 Nov 2019 04:22 PM
RNS
Director/PDMR Shareholding
06 Nov 2019 04:36 PM
RNS
Director/PDMR Shareholding
04 Nov 2019 05:35 PM
RNS
Director/PDMR Shareholding
01 Nov 2019 05:19 PM
RNS
Director/PDMR Shareholding
01 Nov 2019 09:53 AM
RNS
Total Voting Rights
31 Oct 2019 01:34 PM
RNS
Director/PDMR Shareholding
30 Oct 2019 05:32 PM
RNS
Director/PDMR Shareholding
30 Oct 2019 12:07 PM
RNS
Second Price Monitoring Extn
30 Oct 2019 12:02 PM
RNS
Price Monitoring Extension
30 Oct 2019 12:00 PM
RNS
3rd Quarter Results
21 Oct 2019 08:00 AM
RNS
GSK divests two travel vaccines to Bavarian Nordic
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
11 Oct 2019 05:34 PM
RNS
Director/PDMR Shareholding
11 Oct 2019 04:10 PM
RNS
Director/PDMR Shareholding
10 Oct 2019 04:18 PM
RNS
Director/PDMR Shareholding
01 Oct 2019 06:18 PM
RNS
Director/PDMR Shareholding
01 Oct 2019 01:09 PM
RNS
Total Voting Rights
30 Sep 2019 07:00 AM
RNS
PRIMA shows Zejula improves PFS in ovarian cancer
30 Sep 2019 07:00 AM
RNS
Data show anti-tumour activity with ICOS agonist
26 Sep 2019 06:26 PM
RNS
Director/PDMR Shareholding
17 Sep 2019 05:46 PM
RNS
Director/PDMR Shareholding
11 Sep 2019 04:30 PM
RNS
Director/PDMR Shareholding
04 Sep 2019 05:37 PM
RNS
Director/PDMR Shareholding
04 Sep 2019 12:36 PM
RNS
Director/PDMR Shareholding
04 Sep 2019 09:33 AM
RNS
Director/PDMR Shareholding
02 Sep 2019 11:29 AM
RNS
Total Voting Rights
23 Aug 2019 07:00 AM
RNS
GSK - positive results from pivotal DREAMM-2 study
22 Aug 2019 07:00 AM
RNS
ViiV results positive for every 2 month injection
21 Aug 2019 08:00 AM
RNS
GSK submits regulatory file in Japan: Daprodustat

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings